EDGAR Filing Documents for 0001140361-17-013500

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001140361-17-013500

Filing Date

2017-03-27

Accepted

2017-03-27 19:08:16

Documents

Period of Report

2017-03-23

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	doc1.html	4
1	FORM 4	doc1.xml	4	4550
	Complete submission text file	0001140361-17-013500.txt		6268

Mailing Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BUILDING 200, STE. 2203 CAMBRIDGE MA 02139 (857) 999-0075

KalVista Pharmaceuticals, Inc. (Issuer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BOSTON PLACE 201 WASHINGTON STREET, SUITE 3900 BOSTON MA 02108

Business Address

Type: 4 | Act: 34 | File No.: 001-36830 | Film No.: 17716465